8-K: Expensify Faces Nasdaq Delisting Warning Over Stock Price

Expensify, Inc. has received a deficiency letter from Nasdaq indicating its stock price has fallen below the $1.00 minimum for continued listing, with 180 days to regain compliance.

Summary

• Expensify, Inc. received a deficiency letter from Nasdaq on April 17, 2026, due to its Class A common stock closing below $1.00 for 30 consecutive business days.
• The company has until October 14, 2026, to regain compliance by having its stock close at $1.00 or higher for at least ten consecutive business days.
• If compliance is not met, Expensify may be eligible to transfer to The Nasdaq Capital Market and receive an additional 180 days to comply, potentially requiring a reverse stock split.
• Shareholders will vote on a reverse stock split proposal at the Annual Meeting on May 22, 2026, with options for 1-for-15, 1-for-20, or 1-for-25 ratios.
• The Board of Directors will have the discretion to implement a reverse stock split if approved, but there is no guarantee of regaining compliance or approval of the amendments.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing negatively due to the Nasdaq deficiency notice and the potential for delisting, despite the company's stated intentions to address the issue.

Positives

• The Nasdaq deficiency letter does not immediately affect the trading of Expensify's Class A common stock, which continues to trade on The Nasdaq Global Select Market.
• The company has a 180-day compliance period, until October 14, 2026, to meet the minimum bid price requirement.
• Expensify may be eligible for an additional 180-day compliance period if it transfers to The Nasdaq Capital Market and meets other requirements.

Negatives

• Expensify's Class A common stock has fallen below the $1.00 minimum bid price requirement for continued listing on The Nasdaq Global Select Market.
• Failure to regain compliance by October 14, 2026, could lead to delisting from Nasdaq.
• There is no assurance that the proposed reverse stock split amendments will be approved by shareholders.
• Even if approved, there is no guarantee that a reverse stock split will enable the company to regain compliance with Nasdaq listing rules.

Risks

• The primary risk is the potential delisting of Expensify's Class A common stock from The Nasdaq Global Select Market if the minimum bid price requirement is not met by October 14, 2026.
• There is a risk that shareholders may not approve the proposed reverse stock split amendments at the Annual Meeting.
• Even with shareholder approval, the Board may decide not to implement a reverse stock split, or the chosen ratio may not be effective in raising the stock price.
• The company may not be able to regain compliance with the Minimum Bid Price Requirement or other Nasdaq Listing Rules even with a reverse stock split.
• The company faces risks associated with potential delisting, which could negatively impact liquidity and investor confidence.

Future Outlook

Expensify is actively monitoring its stock price and considering options to regain compliance with Nasdaq's minimum bid price requirement, including a potential reverse stock split. The company has a 180-day period to achieve compliance, with potential for an extension under specific conditions. Shareholder approval for reverse stock split amendments is required.

Management Comments

• The Company intends to monitor the closing bid price of its Class A common stock and may, if appropriate, consider available options to regain compliance with the Minimum Bid Price Requirement, including potentially seeking to effect a reverse stock split.

Industry Context

StockSavvy.ai notes that Nasdaq listing rule violations, particularly concerning minimum bid prices, are not uncommon for companies experiencing market headwinds. The proposed reverse stock split is a common tactic employed by companies to artificially inflate their per-share price to meet exchange requirements, though its long-term effectiveness in addressing underlying business issues is debated.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential dilution if a reverse stock split is enacted without a corresponding increase in market capitalization; risk of delisting impacting liquidity and investment value.
• Employees: Potential impact on morale and stock-based compensation value if the stock price continues to decline or if delisting occurs.
• Creditors: While not directly impacted by the stock price, a delisting could signal financial distress, potentially affecting credit perception.

Next Steps

• Monitor the closing bid price of Class A common stock.
• Shareholders to vote on reverse stock split amendments at the Annual Meeting on May 22, 2026.
• Board of Directors to decide on implementing a reverse stock split if amendments are approved.
• Regain compliance with the Minimum Bid Price Requirement by October 14, 2026.
• Potentially transfer to The Nasdaq Capital Market if initial compliance is not met.

Key Dates

Recommendation

The filing indicates a significant concern regarding the company's stock price falling below Nasdaq's minimum bid requirement, necessitating a potential reverse stock split. While the company has a compliance period and a plan, the uncertainty surrounding shareholder approval and the effectiveness of the split warrants a cautious 'hold' stance until compliance is demonstrated.

Keywords

Expensify, Nasdaq, Delisting, Stock Price, Reverse Stock Split, Compliance, Listing Rules, EXFY